ID   FU-MMT-2
AC   CVCL_U144
SY   Fukuoka University-Malignant mixed Mullerian Tumor-2
DR   Wikidata; Q54835240
RX   PubMed=1312893;
RX   PubMed=8774655;
CC   Population: Japanese.
CC   Doubling time: 30 hours (Note=At 5th passage) (PubMed=1312893).
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
CH   CVCL_U145 ! FU-MMT-2-C1
CH   CVCL_U146 ! FU-MMT-2-S1
//
RX   PubMed=1312893; DOI=10.1002/1097-0142(19920401)69:7<1759::AID-CNCR2820690718>3.0.CO;2-Z;
RA   Emoto, Makoto
RA   Iwasaki, Hiroshi
RA   Kikuchi, Masahiro
RA   Ishiguro, Masako
RA   Kubota, Takaaki
RA   Izumi, Hidetaka
RA   Shirakawa, Koichi
RA   Kaneko, Yasuhiko
RT   "Two cell lines established from mixed Mullerian tumors of the uterus.
RT   Morphologic, immunocytochemical, and cytogenetic analyses.";
RL   Cancer 69:1759-1768(1992).
//
RX   PubMed=8774655; DOI=10.1006/gyno.1996.0071;
RA   Emoto, Makoto
RA   Iwasaki, Hiroshi
RA   Kikuchi, Masahiro
RA   Shirakawa, Koichi
RT   "Tissue polypeptide antigen production in a uterine carcinosarcoma
RT   cell line in a serum-free culture.";
RL   Gynecol. Oncol. 60:443-449(1996).
//